n(g)-aminoarginine has been researched along with neuropeptide y in 1 studies
| Studies (n(g)-aminoarginine) | Trials (n(g)-aminoarginine) | Recent Studies (post-2010) (n(g)-aminoarginine) | Studies (neuropeptide y) | Trials (neuropeptide y) | Recent Studies (post-2010) (neuropeptide y) |
|---|---|---|---|---|---|
| 21 | 1 | 2 | 10,663 | 152 | 2,269 |
| Protein | Taxonomy | n(g)-aminoarginine (IC50) | neuropeptide y (IC50) |
|---|---|---|---|
| Neuropeptide Y receptor type 1 | Homo sapiens (human) | 0.0014 | |
| Neuropeptide Y receptor type 2 | Homo sapiens (human) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hodges, GJ; Sparks, PA | 1 |
1 other study(ies) available for n(g)-aminoarginine and neuropeptide y
| Article | Year |
|---|---|
Noradrenaline and neuropeptide Y contribute to initial, but not sustained, vasodilatation in response to local skin warming in humans.
Topics: Adult; Arginine; Clonidine; Humans; Male; Neuropeptide Y; Nitric Oxide Synthase Type III; Nitroprusside; Norepinephrine; Propranolol; Skin; Skin Temperature; Vasodilation; Yohimbine | 2014 |